Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesIn vivo efficacy of ABT-255 against drug-sensitive and -resistant Mycobacterium tuberculosis strainsIn vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosisSequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatisFrequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic reviewAdvances in the diagnosis and treatment of tuberculosis.Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysisEpidemiology and treatment of multidrug resistant tuberculosisFluoroquinolones and tuberculosis.Diagnosis of MDR-TB: a developing world problem on a developed world budget.Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.Drug-Resistant Tuberculosis: Challenges and Progress.Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan.Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencingEvaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
P2860
Q24643546-FC7E92B2-F9D1-4E24-9099-8E0FF3ED84AAQ28369035-70FDBC0A-03C2-4A0E-8570-7C0E09EEEBA6Q28379137-84A4AE7A-A778-4ADB-A273-D9A46F7ADB82Q28379245-1B94B5DA-724E-4C35-A0A8-79AA58FD1778Q28545095-059B6AE8-7BDA-4975-B111-3F203CB95A0BQ30353049-6EC8BC54-2BC1-4398-B621-EE1B351C7181Q30419570-F1DB0403-E62A-4D29-9E03-4485FE71090CQ33581286-BEF20A1E-3193-43EC-A9A7-8BBBC5266678Q33710690-84E8F092-3773-4AA8-8FB8-78D6B46C4670Q34519143-93733753-A344-44F1-909B-A3C6A143044CQ34606332-E00D33F6-7B1C-4F77-A606-FC70F41750C9Q34774652-76FB957A-4D59-4A68-8EC0-055D7A7ADFDDQ35067024-26FF7CCE-AEEB-4E25-B807-363A2BA4463DQ35125890-6917E071-BFC4-40EA-B20A-2716D7923620Q35140132-93327218-6D44-4EF9-856A-42AAE034A4EDQ35821755-731929AC-DCFC-41A0-A73A-CAED469276FCQ36924283-BDCC8F3E-4823-4EF8-8A88-595B9FEF2832Q37247758-B17056D0-84B4-4406-8B29-99E8A12B121FQ37392763-ED49DEBF-E320-41AE-B2CB-C7B930AA9A93Q37612996-533700C6-EF61-4E90-BAAD-C05798EC296BQ39496473-BFB23718-8397-4EE3-8E69-AB6C173371FFQ39557385-27454913-379A-4359-892B-FCAA9479B96AQ40469459-36FA0CB2-235B-4A18-8EBB-9468184F10F0Q41070926-7A518D4D-ABE4-46D7-B1C8-63FB15256689Q41901445-87AD9FDA-5AD7-4579-BDCF-D238980B61BE
P2860
Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Characterization of fluoroquin ...... ry and isolated from patients.
@ast
Characterization of fluoroquin ...... ry and isolated from patients.
@en
type
label
Characterization of fluoroquin ...... ry and isolated from patients.
@ast
Characterization of fluoroquin ...... ry and isolated from patients.
@en
prefLabel
Characterization of fluoroquin ...... ry and isolated from patients.
@ast
Characterization of fluoroquin ...... ry and isolated from patients.
@en
P2093
P2860
P356
P1476
Characterization of fluoroquin ...... ry and isolated from patients.
@en
P2093
Alangaden GJ
Manavathu EK
Vakulenko SB
P2860
P304
P356
10.1128/AAC.39.8.1700
P407
P577
1995-08-01T00:00:00Z